Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon

January 25, 2021 Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the […]

Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation

Samsung Bioepis New Headquarters Located in Korea’s ‘Bio Cluster’ of Songdo in the Incheon Free Economic Zone (IFEZ) The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-generation biologic medicines Includes ‘Welfare Center’ with cafeteria, in-house fitness center, and a daycare center A photo accompanying this announcement is available […]

Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinics

January 25, 2021 5-year alliance will provide Vithas Group with state-of-the-art diagnostic imaging, image viewing solutions, and minimally-invasive intervention technology to deliver faster and more accurate diagnosis and treatment to patients Vithas will become a ‘reference technology partner’ for Philips in Spain, giving it fast access to advances and innovations that Philips develops prior to […]

Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care

January 25, 2021 Hospital will have access to Philips’ latest technologies and informatics solutions to enhance the diagnosis, treatment, monitoring and management of patients Multi-year strategic partnership will accelerate clinical research focused on image-guided minimally-invasive therapy, neurology, intensive care units and digital pathology Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global […]

Philips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. operations increases to EUR 608 million, Adjusted EBITA margin improves 110 bps to 19.0%, and operating cash flow increases to EUR 1,305 million

January 25, 2021 Fourth-quarter highlights •        Sales amounted to EUR 6.0 billion, with 7% comparable sales growth •        Comparable order intake increased 7% •        Income from continuing operations increased to EUR 608 million, compared to EUR 550 million in Q4 2019 •        Adjusted EBITA margin increased to 19.0% of sales, compared to 17.9% of sales […]